Evidence map›Paper›PMID 26924641›Full record

ArticleGlycoconjugate journal2016

Acute phase inflammation is characterized by rapid changes in plasma/peritoneal fluid N-glycosylation in mice.

Yoann Rombouts, Hulda S Jónasdóttir, Agnes L Hipgrave Ederveen, Karli R Reiding, Bas C Jansen, Jona Freysdottir, Ingibjörg Hardardottir, Andreea Ioan-Facsinay, Martin Giera, Manfred Wuhrer

Open access · hybridAbstract read
In one paragraph

Article in Glycoconjugate journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yoann RomboutsCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands. yoann.rombouts@ipbs.fr.
Hulda S JónasdóttirCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Agnes L Hipgrave EderveenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Karli R ReidingCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Bas C JansenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Jona FreysdottirFaculty of Medicine, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Ingibjörg HardardottirFaculty of Medicine, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Andreea Ioan-FacsinayDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Martin GieraCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Manfred WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Netherlands Metabolomics Centre · NLLeiden University Medical Center · NLUniversity of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Murine zymosan-induced peritonitis is a widely used model for studying the molecular and cellular events responsible for the initiation, persistence and/or resolution of inflammation. Among these events, it is becoming increasingly evident that changes in glycosylation of proteins, especially in the plasma and at the site of inflammation, play an important role in the inflammatory response. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS)-based glycosylation profiling, we investigated the qualitative and quantitative effect of zymosan-induced peritonitis on N-glycosylation in mouse plasma and peritoneal fluid. Our results show that both N-glycomes exhibit highly similar glycosylation patterns, consisting mainly of diantennary and triantennary complex type N-glycans with high levels (>95 %) of galactosylation and sialylation (mostly NeuGc) and a medium degree of core fucosylation (30 %). Moreover, MS/MS structural analysis, assisted by linkage-specific derivatization of sialic acids, revealed the presence of O-acetylated sialic acids as well as disialylated antennae ("branching sialylation") characterized by the presence of α2-6-linked NeuGc on the GlcNAc of the NeuGcα2-3-Galβ1-3-GlcNAc terminal motif. A significant decrease of (core) fucosylation together with an increase of both α2-3-linked NeuGc and "branching sialylation" were observed in N-glycomes of mice challenged with zymosan, but not in control mice injected with PBS. Importantly, substantial changes in glycosylation were already observed 12 h after induction of peritonitis, thereby demonstrating an unexpected velocity of the biological mechanisms involved.

Indexed as

Protein Processing, Post-TranslationalAcetylglucosamineAcute-Phase ReactionAnimalsAscitic FluidFemaleGlycoproteinsGlycosylationMiceMice, Inbred C57BLPeritonitisAcetylglucosamineGlycoproteinsMouseN-glycosylation changesPeritoneal fluidPlasmaZymosan-induced peritonitis

Identifiers

PMID26924641
PMCPMC4891370
OpenAlexW2290943621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.